ISRG vs. ABT, SYK, BSX, MDT, BDX, EW, DXCM, IDXX, RMD, and ZBH
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Abbott Laboratories (ABT), Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), and Zimmer Biomet (ZBH). These companies are all part of the "medical" sector.
Intuitive Surgical (NASDAQ:ISRG) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.
Intuitive Surgical received 96 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.64% of users gave Abbott Laboratories an outperform vote while only 69.07% of users gave Intuitive Surgical an outperform vote.
Intuitive Surgical has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500.
Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.9% of Intuitive Surgical shares are held by company insiders. Comparatively, 1.1% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, Abbott Laboratories had 3 more articles in the media than Intuitive Surgical. MarketBeat recorded 22 mentions for Abbott Laboratories and 19 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 0.85 beat Abbott Laboratories' score of 0.54 indicating that Intuitive Surgical is being referred to more favorably in the media.
Intuitive Surgical presently has a consensus target price of $403.67, indicating a potential upside of 0.38%. Abbott Laboratories has a consensus target price of $120.64, indicating a potential upside of 18.05%. Given Abbott Laboratories' higher possible upside, analysts clearly believe Abbott Laboratories is more favorable than Intuitive Surgical.
Intuitive Surgical has a net margin of 27.16% compared to Abbott Laboratories' net margin of 13.96%. Abbott Laboratories' return on equity of 20.18% beat Intuitive Surgical's return on equity.
Summary
Intuitive Surgical beats Abbott Laboratories on 11 of the 18 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intuitive Surgical Competitors List
Related Companies and Tools
